
Dr. Matt Helm, PhD: Empowering Individuals, Couples, and Leaders to Lead with Authenticity and Purpose
Ann Arbor, Michigan - Dr. Matt Helm, PhD, a transformative coach and thought leader, is dedicated to empowering individuals, couples, and leaders to reach their fullest potential through innovative coaching methods. With over three decades of experience, Dr. Helm focuses on guiding clients to overcome emotional barriers and embrace a life of authenticity, integrity, and purpose. More information can be found at drmatthelm.com
Credentials That Inspire Growth
Dr. Helm combines his extensive knowledge and experience with a unique approach to personal development. His credentials include:
- Licensed Professional Counselor
- Certified Wellness Director
- Holistic Stress Management Facilitator
- Certified Blueprint™ Coach
- Spiritual Intelligence Coach
Dr. Helm's innovative methods lead clients to achieve what he describes as "Peak Existence." His work has had a profound impact on thousands, helping them navigate challenges and unlock their true potential. For more details on his approach, visit drmatthelm.com/leadership
Unique Selling Points:
- Expert Insights: Dr. Helm offers a fresh perspective on emotional growth, conscious relationships, and leadership.
- Transformational Impact: He has successfully guided numerous individuals and couples in achieving personal transformation.
- Innovative Methods: As a Certified Accelerated Evolution Guide, Dr. Helm utilizes powerful techniques that facilitate rapid and lasting breakthroughs.
- Global Movement: He is a key contributor to a growing initiative aimed at promoting holistic well-being and conscious leadership.
Target Audience:
Dr. Helm's coaching is particularly beneficial for:
- Individuals seeking emotional growth and personal empowerment
- Couples looking to strengthen their relationships and deepen their connections
- Leaders who wish to foster authenticity and vulnerability in their interactions
- Anyone interested in creating a meaningful and fulfilling life
Recent Media Appearances:
- Intimate Conversations Podcast with Alana Pratt
- Voya Miami Magazine
- HEART WARRIORS Podcast: The Sacred Edge of Masculinity
- Chapter 19 of Embody Kind by Brave Healer Press: 'The Awakened Couple—An Embodied Approach to Relationships'
- Best Version Media: 'The Ecstasy of Making Love to Your Life: An Influencer's Guide'
https://drmatthelm.com/dr-matt-press
Key Topics for Interviews:
- The importance of emotional growth for individuals and couples
- Redefining relationships in the modern world
- Strategies for personal transformation and development
- The role of vulnerability in effective leadership
- Creating a fulfilling and purposeful life together
Testimonials:
'Transformed Life and Success'
'Matt has come into my life and ignited a process of growth I never knew was possible, enabling me to take control of my life and move toward purpose, truth, courage, and freedom. There is no more powerful agent for transformation on this earth than Matt Helm.'
— Tyler Duncan, Producer and Composer
'Revitalized Our Journey'
'When we started working with Matt, we faced significant challenges. Through his guidance, we have experienced profound growth and change. His insights have revitalized our journey together.'
— Kegan Gil, Author and Speaker
'Empowered Change'
'This work has opened us up to new perspectives and approaches in our lives. We believe that anyone could benefit from the empowerment and clarity that this coaching provides.'
— Leah Preston, Consultant
Dr. Helm is excited to share his insights on emotional growth and personal empowerment with audiences by podcast or television. For booking inquiries, to schedule an interview, or for editorial opportunities, please contact him at hello@matthelmcoaching.com or (557) 927-5554.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Globe and Mail
7 hours ago
- Globe and Mail
Dr. Matt Helm, PhD: Empowering Individuals, Couples, and Leaders to Lead with Authenticity and Purpose
Ann Arbor, Michigan - Dr. Matt Helm, PhD, a transformative coach and thought leader, is dedicated to empowering individuals, couples, and leaders to reach their fullest potential through innovative coaching methods. With over three decades of experience, Dr. Helm focuses on guiding clients to overcome emotional barriers and embrace a life of authenticity, integrity, and purpose. More information can be found at Credentials That Inspire Growth Dr. Helm combines his extensive knowledge and experience with a unique approach to personal development. His credentials include: - Licensed Professional Counselor - Certified Wellness Director - Holistic Stress Management Facilitator - Certified Blueprint™ Coach - Spiritual Intelligence Coach Dr. Helm's innovative methods lead clients to achieve what he describes as "Peak Existence." His work has had a profound impact on thousands, helping them navigate challenges and unlock their true potential. For more details on his approach, visit Unique Selling Points: - Expert Insights: Dr. Helm offers a fresh perspective on emotional growth, conscious relationships, and leadership. - Transformational Impact: He has successfully guided numerous individuals and couples in achieving personal transformation. - Innovative Methods: As a Certified Accelerated Evolution Guide, Dr. Helm utilizes powerful techniques that facilitate rapid and lasting breakthroughs. - Global Movement: He is a key contributor to a growing initiative aimed at promoting holistic well-being and conscious leadership. Target Audience: Dr. Helm's coaching is particularly beneficial for: - Individuals seeking emotional growth and personal empowerment - Couples looking to strengthen their relationships and deepen their connections - Leaders who wish to foster authenticity and vulnerability in their interactions - Anyone interested in creating a meaningful and fulfilling life Recent Media Appearances: - Intimate Conversations Podcast with Alana Pratt - Voya Miami Magazine - HEART WARRIORS Podcast: The Sacred Edge of Masculinity - Chapter 19 of Embody Kind by Brave Healer Press: 'The Awakened Couple—An Embodied Approach to Relationships' - Best Version Media: 'The Ecstasy of Making Love to Your Life: An Influencer's Guide' Key Topics for Interviews: - The importance of emotional growth for individuals and couples - Redefining relationships in the modern world - Strategies for personal transformation and development - The role of vulnerability in effective leadership - Creating a fulfilling and purposeful life together Testimonials: 'Transformed Life and Success' 'Matt has come into my life and ignited a process of growth I never knew was possible, enabling me to take control of my life and move toward purpose, truth, courage, and freedom. There is no more powerful agent for transformation on this earth than Matt Helm.' — Tyler Duncan, Producer and Composer 'Revitalized Our Journey' 'When we started working with Matt, we faced significant challenges. Through his guidance, we have experienced profound growth and change. His insights have revitalized our journey together.' — Kegan Gil, Author and Speaker 'Empowered Change' 'This work has opened us up to new perspectives and approaches in our lives. We believe that anyone could benefit from the empowerment and clarity that this coaching provides.' — Leah Preston, Consultant Dr. Helm is excited to share his insights on emotional growth and personal empowerment with audiences by podcast or television. For booking inquiries, to schedule an interview, or for editorial opportunities, please contact him at hello@ or (557) 927-5554.


CBC
10 hours ago
- CBC
Twice-a-year shot to prevent HIV approved in U.S.
The U.S. has approved the world's only twice-a-year shot to prevent HIV, its maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions — although it's unclear how many in the U.S. and abroad will get access to the powerful new option. While a vaccine to prevent HIV still is needed, some experts say this medication — a drug called lenacapavir — could be the next best thing. It nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take. "This really has the possibility of ending HIV transmission," said Greg Millett, public policy director at amfAR, the Foundation for AIDS Research. Condoms help guard against HIV infection if used properly, but something called PrEP — regularly using preventive medicines, such as the daily pills or a different shot given every two months — is increasingly important. Lenacapavir's six-month protection makes it the longest-lasting type — an option that could attract people wary of more frequent doctor visits or stigma from daily pills. But upheaval in U.S. health care — including cuts to public health agencies and Medicaid — and slashing of American foreign aid to fight HIV are clouding the prospects. Millett said "gaping holes in the system" in the U.S. and globally "are going to make it difficult for us to make sure we not only get lenacapavir into people's bodies, but make sure they come back," even as little as twice a year. Gilead's drug is already sold to treat HIV under the brand name Sunlenca, which is listed as approved in Health Canada's database. The prevention dose will be sold under a different name, Yeztugo. It's given as two injections under the skin of the abdomen, leaving a small "depot" of medication to slowly absorb into the body. Gilead didn't immediately announce its price. The drug only prevents HIV transmission; it doesn't block other sexually transmitted diseases. WATCH | HIV prevention drug comes to Canada: Quebec becomes 1st province to cover new HIV prevention drug 3 months ago Duration 2:02 Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide. Only about 400,000 Americans already use some form of PrEP, a fraction of those estimated to benefit. A recent study found states with high use of PrEP saw a decrease in HIV infections, while rates continued rising elsewhere. Trial participant says he forgets he's on PrEP About half of new infections are in women, who often need protection they can use without a partner's knowledge or consent. One rigorous study in South Africa and Uganda compared more than 5,300 sexually active young women and teen girls given twice-yearly lenacapavir or the daily pills. There were no HIV infections in those receiving the shot, while about two per cent in the comparison group caught HIV from infected sex partners. A second study found the twice-yearly shot nearly as effective in gay men and gender-non-conforming people in the U.S. and in several other countries hard-hit by HIV. Ian Haddock, who lives in Houston, had tried PrEP off and on since 2015. But he jumped at the chance to participate in the lenacapavir study and continues with the twice-yearly shots as part of the research followup. "Now I forget that I'm on PrEP because I don't have to carry around a pill bottle," said Haddock, who leads the Normal Anomaly Initiative, a non-profit serving Black 2SLGBTQ+ communities. "Men, women, gay, straight — it really just kind of expands the opportunity for prevention," he said. Just remembering a clinic visit every six months "is a powerful tool versus constantly having to talk about, like, condoms, constantly making sure you're taking your pill every day," Haddock added. "Everyone in every country who's at risk of HIV needs access to PrEP," said Dr. Gordon Crofoot, who helped lead the study in men. "We need to get easier access to PrEP that's highly effective, like this is."


CTV News
12 hours ago
- CTV News
U.S. FDA approves the world's only twice-a-year shot to prevent HIV
A pharmacist holds a vial of lenacapavir, an injectable HIV prevention drug, at the Desmond Tutu Health Foundation's Masiphumelele Research Site, in Cape Town, South Africa, Tuesday, July 23, 2024, which was one of the sites for Gilead's lenacapavir drug trial. (AP Photo/Nardus Engelbrecht, File) WASHINGTON — The U.S. has approved the world's only twice-a-year shot to prevent HIV, maker Gilead Sciences announced Wednesday. It's the first step in an anticipated global rollout that could protect millions – although it's unclear how many in the U.S. and abroad will get access to the powerful new option. While a vaccine to prevent HIV still is needed, some experts say the shot — a drug called lenacapvir — could be the next best thing. It nearly eliminated new infections in two groundbreaking studies of people at high risk, better than daily preventive pills they can forget to take. 'This really has the possibility of ending HIV transmission,' said Greg Millett, public policy director at amfAR, The Foundation for AIDS Research. Condoms help guard against HIV infection if used properly but what's called PrEP — regularly using preventive medicines such as the daily pills or a different shot given every two months — is increasingly important. Lenacapavir's six-month protection makes it the longest-lasting type, an option that could attract people wary of more frequent doctor visits or stigma from daily pills. But upheaval in U.S. healthcare — including cuts to public health agencies and Medicaid — and slashing of American foreign aid to fight HIV are clouding the prospects. Millett said 'gaping holes in the system' in the U.S. and globally 'are going to make it difficult for us to make sure we not only get lenacapavir into people's bodies but make sure they come back' even as little as twice a year. Gilead's drug already is sold to treat HIV under the brand name Sunlenca. The prevention dose will be sold under a different name, Yeztugo. It's given as two injections under the skin of the abdomen, leaving a small 'depot' of medication to slowly absorb into the body. Gilead didn't immediately announce its price. The drug only prevents HIV transmission – it doesn't block other sexually transmitted diseases. Global efforts at ending the HIV pandemic by 2030 have stalled. There still are more than 30,000 new infections in the U.S. each year and about 1.3 million worldwide. Only about 400,000 Americans already use some form of PrEP, a fraction of those estimated to benefit. A recent study found states with high use of PrEP saw a decrease in HIV infections, while rates continued rising elsewhere. About half of new infections are in women, who often need protection they can use without a partner's knowledge or consent. One rigorous study in South Africa and Uganda compared more than 5,300 sexually active young women and teen girls given twice-yearly lenacapavir or the daily pills. There were no HIV infections in those receiving the shot while about two per cent in the comparison group caught HIV from infected sex partners. A second study found the twice-yearly shot nearly as effective in gay men and gender-nonconforming people in the U.S. and in several other countries hard-hit by HIV. Ian Haddock of Houston had tried PrEP off and on since 2015 but he jumped at the chance to participate in the lenacapavir study and continues with the twice-yearly shots as part of the research follow-up. 'Now I forget that I'm on PrEP because I don't have to carry around a pill bottle,' said Haddock, who leads the Normal Anomaly Initiative, a nonprofit serving Black LGBTQ2S+ communities. 'Men, women, gay, straight – it really just kinds of expands the opportunity for prevention,' he added. Just remembering a clinic visit every six months 'is a powerful tool versus constantly having to talk about, like, condoms, constantly making sure you're taking your pill every day.' 'Everyone in every country who's at risk of HIV needs access to PrEP,' added Dr. Gordon Crofoot of Houston, who helped lead the study in men. 'We need to get easier access to PrEP that's highly effective like this is.' Lauran Neergaard, The Associated Press